questionText: To ask the Secretary of State for Health and Social Care, whether he plans to take steps with NHS England to expand access to indication-specific pricing agreements.
answerText: As part of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth, NHS England committed to undertake two consultations on amendments to the NHS Commercial Framework for New Medicines. The first of these was launched on 31 July 2024 an...
heading: Drugs: Prices